X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (6679) 6679
Book Chapter (216) 216
Book / eBook (40) 40
Publication (19) 19
Dissertation (9) 9
Conference Proceeding (7) 7
Journal / eJournal (2) 2
Data Set (1) 1
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (3816) 3816
index medicus (3461) 3461
animals (2107) 2107
cns (1998) 1998
female (1981) 1981
male (1958) 1958
neurosciences (1746) 1746
oncology (1560) 1560
clinical neurology (1301) 1301
central-nervous-system (1255) 1255
central nervous system (1213) 1213
adult (1195) 1195
middle aged (1127) 1127
brain (990) 990
mice (938) 938
primary cns lymphoma (936) 936
chemotherapy (862) 862
aged (856) 856
cancer (795) 795
neurology (705) 705
nervous system (690) 690
medicine & public health (633) 633
adolescent (627) 627
child (625) 625
tumors (596) 596
magnetic resonance imaging (587) 587
expression (562) 562
rats (547) 547
research (534) 534
hematology (520) 520
surgery (520) 520
radiotherapy (516) 516
diagnosis (514) 514
prognosis (505) 505
cell biology (495) 495
analysis (488) 488
lymphomas (486) 486
care and treatment (477) 477
immunology (470) 470
survival (468) 468
inflammation (457) 457
retrospective studies (438) 438
pathology (433) 433
treatment outcome (429) 429
child, preschool (426) 426
biochemistry & molecular biology (425) 425
brain tumors (421) 421
immunohistochemistry (416) 416
children (411) 411
multiple sclerosis (401) 401
pediatrics (401) 401
cells, cultured (396) 396
neurons (380) 380
brain neoplasms - pathology (374) 374
health aspects (372) 372
therapy (362) 362
mice, inbred c57bl (357) 357
multiple-sclerosis (353) 353
lymphoma (352) 352
microglia (345) 345
pharmacology & pharmacy (342) 342
gene expression (337) 337
proteins (335) 335
blood-brain barrier (331) 331
infant (330) 330
methotrexate (327) 327
young adult (324) 324
aged, 80 and over (323) 323
non-hodgkins-lymphoma (313) 313
risk factors (302) 302
cns tumors (301) 301
cytokines (298) 298
radiology, nuclear medicine & medical imaging (295) 295
stem cells (295) 295
antineoplastic combined chemotherapy protocols - therapeutic use (294) 294
disease models, animal (294) 294
cells (290) 290
disease (288) 288
brain - pathology (285) 285
combined modality therapy (285) 285
central nervous system neoplasms - pathology (281) 281
radiation-therapy (272) 272
apoptosis (266) 266
metastasis (265) 265
biomedicine (262) 262
glioblastoma (262) 262
review (255) 255
experimental autoimmune encephalomyelitis (254) 254
activation (248) 248
patients (246) 246
astrocytes (245) 245
differentiation (245) 245
brain - metabolism (243) 243
glioma (241) 241
high-dose methotrexate (240) 240
medicine (240) 240
brain neoplasms - drug therapy (238) 238
multidisciplinary sciences (236) 236
transplantation (234) 234
diagnosis, differential (232) 232
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (18) 18
Collection Dvlpm't (Acquisitions) - Vendor file (5) 5
Collection Dvlpm't (Acquisitions) - Closed Orders (3) 3
Online Resources - Online (2) 2
Sunnybrook Health Sciences Centre - Sunnybrook Stacks (2) 2
UofT at Scarborough - Stacks (2) 2
Providence Healthcare - Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (6809) 6809
German (54) 54
French (39) 39
Japanese (33) 33
Spanish (33) 33
Polish (11) 11
Czech (7) 7
Italian (6) 6
Korean (5) 5
Russian (5) 5
Chinese (4) 4
Swedish (3) 3
Hungarian (1) 1
Persian (1) 1
Portuguese (1) 1
Turkish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


2012, Biomedical & nanomedical technologies, ISBN 9780791860038, viii, 99
Book
Nature, ISSN 0028-0836, 04/2015, Volume 520, Issue 7547, pp. 368 - 372
... to incomplete tumour regression. The tumour-promoting secretome of melanoma cells treated with the kinase inhibitor vemurafenib is driven by down-regulation of the transcription factor FRA1... 
CNS CELL-TYPES | MELANOMA | METASTASIS | MICROENVIRONMENT | TRANSLATIONAL PROFILING APPROACH | MULTIDISCIPLINARY SCIENCES | RAF INHIBITOR RESISTANCE | ACQUIRED-RESISTANCE | KINASE INHIBITORS | DRUG-RESISTANCE | CANCER CHEMORESISTANCE | Lung Neoplasms - drug therapy | Adenocarcinoma - pathology | Clone Cells - drug effects | Humans | Lung Neoplasms - metabolism | Lung Neoplasms - pathology | Proto-Oncogene Proteins c-fos - deficiency | Adenocarcinoma - metabolism | Anaplastic Lymphoma Kinase | Neoplasm Metastasis - drug therapy | Receptor Protein-Tyrosine Kinases - antagonists & inhibitors | Female | Proto-Oncogene Proteins c-akt - metabolism | Melanoma - metabolism | Tumor Microenvironment - drug effects | Cell Survival - drug effects | ErbB Receptors - antagonists & inhibitors | Melanoma - pathology | Down-Regulation - drug effects | Enzyme Activation - drug effects | Adenocarcinoma - drug therapy | Disease Progression | Proto-Oncogene Proteins B-raf - antagonists & inhibitors | Cell Movement - drug effects | Animals | Clone Cells - pathology | Metabolome - drug effects | Signal Transduction - drug effects | Neoplasm Metastasis - pathology | Protein Kinase Inhibitors - therapeutic use | Melanoma - drug therapy | Cell Line, Tumor | Cell Proliferation - drug effects | Mice | Protein Kinase Inhibitors - pharmacology | Drug Resistance, Neoplasm - drug effects | Antimitotic agents | Pharmaceutical research | Care and treatment | Oncology, Experimental | Dosage and administration | Research | Drug therapy | Drug resistance | Antineoplastic agents | Tumors | Cancer | Melanoma | Mutation | Metastasis | Kinases | Cancer therapies
Journal Article
by Sturm, Dominik and Orr, Brent A and Toprak, Umut H and Hovestadt, Volker and Jones, David T.W and Capper, David and Sill, Martin and Buchhalter, Ivo and Northcott, Paul A and Leis, Irina and Ryzhova, Marina and Koelsche, Christian and Pfaff, Elke and Allen, Sariah J and Balasubramanian, Gnanaprakash and Worst, Barbara C and Pajtler, Kristian W and Brabetz, Sebastian and Johann, Pascal D and Sahm, Felix and Reimand, Jüri and Mackay, Alan and Carvalho, Diana M and Remke, Marc and Phillips, Joanna J and Perry, Arie and Cowdrey, Cynthia and Drissi, Rachid and Fouladi, Maryam and Giangaspero, Felice and Łastowska, Maria and Grajkowska, Wiesława and Scheurlen, Wolfram and Pietsch, Torsten and Hagel, Christian and Gojo, Johannes and Lötsch, Daniela and Berger, Walter and Slavc, Irene and Haberler, Christine and Jouvet, Anne and Holm, Stefan and Hofer, Silvia and Prinz, Marco and Keohane, Catherine and Fried, Iris and Mawrin, Christian and Scheie, David and Mobley, Bret C and Schniederjan, Matthew J and Santi, Mariarita and Buccoliero, Anna M and Dahiya, Sonika and Kramm, Christof M and von Bueren, André O and von Hoff, Katja and Rutkowski, Stefan and Herold-Mende, Christel and Frühwald, Michael C and Milde, Till and Hasselblatt, Martin and Wesseling, Pieter and Rößler, Jochen and Schüller, Ulrich and Ebinger, Martin and Schittenhelm, Jens and Frank, Stephan and Grobholz, Rainer and Vajtai, Istvan and Hans, Volkmar and Schneppenheim, Reinhard and Zitterbart, Karel and Collins, V. Peter and Aronica, Eleonora and Varlet, Pascale and Puget, Stephanie and Dufour, Christelle and Grill, Jacques and Figarella-Branger, Dominique and Wolter, Marietta and Schuhmann, Martin U and Shalaby, Tarek and Grotzer, Michael and van Meter, Timothy and Monoranu, Camelia-Maria and Felsberg, Jörg and Reifenberger, Guido and Snuderl, Matija and Forrester, Lynn Ann and Koster, Jan and Versteeg, Rogier and Volckmann, Richard and van Sluis, Peter and Wolf, Stephan and Mikkelsen, Tom and Gajjar, Amar and Aldape, Kenneth and Moore, Andrew S and Taylor, Michael D and Jones, Chris and ...
Cell, ISSN 0092-8674, 02/2016, Volume 164, Issue 5, pp. 1060 - 1072
Journal Article
Cancer, ISSN 0008-543X, 12/2013, Volume 119, Issue 23, pp. 4180 - 4187
Journal Article
Neuro-Oncology, ISSN 1522-8517, 12/2017, Volume 19, Issue 12, pp. 1661 - 1672
Background. Following promising results to increase survival and reduce treatment burden in intracranial non-germinomatous germ cell tumors (NGGCTs... 
intracranial non-germinoma | toxicity | radiotherapy | relapse | chemotherapy | MANAGEMENT | CNS | MAKEI-89 | PRIMARY CHEMOTHERAPY | CLINICAL NEUROLOGY | IRRADIATION | PHASE-II TRIAL | THERAPY | IMPROVED PROGNOSIS | ONCOLOGY | COOPERATIVE TRIAL | CENTRAL-NERVOUS-SYSTEM | Clinical Investigations
Journal Article
Proceedings of the National Academy of Sciences of the United States of America, ISSN 0027-8424, 8/2015, Volume 112, Issue 31, pp. 9704 - 9709
Journal Article
2004, ISBN 9780763722616, xix, 344 p., 12 p. of plates
Book